Marco Caminati
0000-0001-7383-1487
14 papers found
Refreshing results…
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group
Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID ‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose
Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real‐life observation
Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
Missing publications? Search for publications with a matching author name.